328 related articles for article (PubMed ID: 31815781)
21. Targeted Therapy in Pediatric AML: An Evolving Landscape.
Jones LM; Tarlock K; Cooper T
Paediatr Drugs; 2021 Sep; 23(5):485-497. PubMed ID: 34420195
[TBL] [Abstract][Full Text] [Related]
22. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
23. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
25. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
26. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
[TBL] [Abstract][Full Text] [Related]
27. [Acute myeloid leukemia].
Tabuchi K
Gan To Kagaku Ryoho; 2007 Feb; 34(2):156-61. PubMed ID: 17301520
[TBL] [Abstract][Full Text] [Related]
28. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.
Falini B; Martelli MP
Best Pract Res Clin Haematol; 2015; 28(2-3):90-7. PubMed ID: 26590764
[TBL] [Abstract][Full Text] [Related]
29. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
30. AML treatment: conventional chemotherapy and emerging novel agents.
Forsberg M; Konopleva M
Trends Pharmacol Sci; 2024 May; 45(5):430-448. PubMed ID: 38643058
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and Therapy of Acute Myeloid Leukemia].
Medinger M; Heim D; Halter JP; Lengerke C; Passweg JR
Ther Umsch; 2019; 76(9):481-486. PubMed ID: 32157963
[TBL] [Abstract][Full Text] [Related]
32. Advances in acute myeloid leukemia.
Newell LF; Cook RJ
BMJ; 2021 Oct; 375():n2026. PubMed ID: 34615640
[TBL] [Abstract][Full Text] [Related]
33. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.
Venditti A; Piciocchi A; Candoni A; Melillo L; Calafiore V; Cairoli R; de Fabritiis P; Storti G; Salutari P; Lanza F; Martinelli G; Luppi M; Mazza P; Martelli MP; Cuneo A; Albano F; Fabbiano F; Tafuri A; Chierichini A; Tieghi A; Fracchiolla NS; Capelli D; Foà R; Alati C; La Sala E; Fazi P; Vignetti M; Maurillo L; Buccisano F; Del Principe MI; Irno-Consalvo M; Ottone T; Lavorgna S; Voso MT; Lo-Coco F; Arcese W; Amadori S
Blood; 2019 Sep; 134(12):935-945. PubMed ID: 31395600
[TBL] [Abstract][Full Text] [Related]
34. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
[TBL] [Abstract][Full Text] [Related]
35. Current treatment of acute myeloid leukemia.
Roboz GJ
Curr Opin Oncol; 2012 Nov; 24(6):711-9. PubMed ID: 23014187
[TBL] [Abstract][Full Text] [Related]
36. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Gomez-Arteaga A; Gyurkocza B
Curr Opin Hematol; 2020 Mar; 27(2):115-121. PubMed ID: 31913152
[TBL] [Abstract][Full Text] [Related]
38. [Advances in targeted therapy for childhood acute myeloid leukemia].
Wang NN; Ye QD
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):832-836. PubMed ID: 28697841
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
[TBL] [Abstract][Full Text] [Related]
40. [Acute myeloid leukemia].
Döhner K; Paschka P; Döhner H
Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
